ALT vs. METCB

In the year-to-date period, ALT achieves a -26.49% return, which is significantly lower than METCB's -22.95% return.

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

This table presents a comparison of risk-adjusted performance metrics for Altimmune, Inc. (ALT) and Ramaco Resources Inc. (METCB). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

The current ALT Sharpe Ratio is -0.36, which is higher than the METCB Sharpe Ratio of -0.56. The chart below compares the historical Sharpe Ratios of ALT and METCB, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

ALT has not paid dividends to shareholders, while METCB's dividend yield for the trailing twelve months is around 8.22%.

The maximum ALT drawdown since its inception was -99.94%, which is greater than METCB's maximum drawdown of -57.23%. Use the drawdown chart below to compare losses from any high point for ALT and METCB.

Altimmune, Inc. (ALT) has a higher volatility of 23.45% compared to Ramaco Resources Inc. (METCB) at 15.27%. This indicates that ALT's price experiences larger fluctuations and is considered to be riskier than METCB based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

This section allows you to compare key financial metrics between Altimmune, Inc. and Ramaco Resources Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.